Protara Therapeutics: Pay

Protara Therapeutics paid its 3 named executives $5.4M in total in FY2025 (Dec). CEO Jesse Shefferman was paid $2.7M of that.

Pay$100 in the stock at the end of FY21 → $79
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Jesse SheffermanPresident, Chief Executive Officer and Director
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years
Leonardo Nicacio, M.D.Chief Medical Officer
FY2025 (Dec)
1 year
Jacqueline Zummo, Ph.D.Chief R&D Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
4 years

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.